EMJ GOLD: Pharma news, views and analysis
EMJ
Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm.
Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
Episodes
Mentioned books
Apr 20, 2021 • 22min
Talking to Timothy White
This week, we sit down with Timothy White, Vice President and Head of Global Digital Commercial, Teva Pharmaceuticals, to explore the subject of digital transformation. He discusses the 'four Es' of digital content, shares insight from the news and education platform NeurologyBytes, and reflects on his time working in the music industry.
Apr 13, 2021 • 29min
Talking to Paul Simms
This week, we are joined by Paul Simms, Chief Executive, Impatient Health and Pharma Provocateur, who shares his experience of the past year, the importance of overcoming red tape in pursuit of innovation, and his predictions for the pharmaceutical industry in 2021.
Apr 6, 2021 • 5min
Pharma's Month in Review - Apr 2021
This week, we reflect on March in pharma and the key happenings from the month. We will be covering the latest in COVID-19 and vaccine developments, the most prestigious mergers and acquisitions, the latest in research and development, and more.
Mar 30, 2021 • 23min
Talking to Claudia Martinez
This week, we sit down with Claudia Martinez, Research Programme Manager, Access to Medicine Foundation, who explains the methodology behind the Access to Medicine Foundation's 2021 Index, why access to medicine is still a challenge for the pharmaceutical industry, and how companies can adapt their processes to reach to most vulnerable patient populations.
Mar 23, 2021 • 27min
Talking to Rob Jekielek
This week, we talk to Rob Jekielek, Managing Director, The Harris Poll, to explore evolving public perceptions of the pharmaceutical industry, considering how the progress made during COVID-19 can be sustained and what is needed to ensure their reputation improves even further.
Mar 16, 2021 • 33min
Talking to Jose Maria (Chema) Guido Avila
This week, we sit down with Jose Maria (Chema) Guido Avila, Global Lead HCP Marketing, Sanofi, to hear his thoughts on the importance of combating misinformation, what metrics are most appropriate to measure the success of virtual events, and why Germany should be on everyone's travel list.
Mar 9, 2021 • 39min
Talking to Ipsen's UK & Ireland Team
This week, we are joined by four esteemed guests from Ipsen's UK & Ireland team, including Asad Mohsin Ali, Managing Director, to discuss the fabric and value of high-performing teams, especially against a backdrop of the COVID-19 crisis.
Mar 2, 2021 • 5min
Pharma's Month in Review - March 2021
This week, we reflect on February's month in the pharmaceutical industry, covering the latest in vaccine developments, the most promising mergers and acquisitions, and work at The European Commission which could encourage further international collaborations into 2021 and beyond.
Feb 23, 2021 • 56min
Talking to Uzair Qadeer
This week, we speak to Uzair Qadeer, Chief Diversity Officer, Alexion, to reflect on his notable career as a HR futurist, understand how diversity and belonging are business imperatives for the pharmaceutical industry, and why Italy has been his favourite place to live to date.
Feb 16, 2021 • 16min
Talking to Kevin O'Brien
This week, we talk to Kevin O'Brien, President, North America, Merz Therapeutics, about the intricacies of developing a treatment for a new indication, translating a company culture online, and leadership lessons he has learnt because of COVID-19. Please note the product discussed in this podcast has a black box warning and could result in potentially serious side effects.
